Marker Therapeutics Inc
NASDAQ:MRKR 9:54:58 AM EDT
| Market Cap (Intraday) | 17.03M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $1.50 |
| 50-Day MA | $1.34 |
| 200-Day MA | $2.26 |
Marker Therapeutics Inc Stock, NASDAQ:MRKR
2450 Holcombe Boulevard, Suite BCM-A, MS: BCM251, Houston, Texas 77021
United States of America
Phone: +1.713.400.6400
Number of Employees: 8
Description
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.